The Effects of Eccentric-focused Exercise on Posterior Shoulder Tightness in Symptomatic Overhead Athletes

August 22, 2023 updated by: National Yang Ming University

The Effects of Eccentric-focused Exercise on Shoulder Mobility, Rotator Cuff Strength, Pain and Dysfunction, Scapular Kinematics and Muscle Activation in Symptomatic Overhead Athletes With Posterior Shoulder Tightness

The aim of this study is to investigate the effects of shoulder eccentric exercise training on shoulder mobility, rotator cuff strength, pain and dysfunction, scapular kinematics and muscle activation in symptomatic overhead athletes with posterior shoulder tightness.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Overhead athletes commonly have posterior shoulder tightness due to repetitively high tensile loading during overhead throwing. However, intervention studies focused on posterior shoulder tightness in people with subacromial pain are still limited. Additionally, eccentric exercise was thought to improve the eccentric strength and neuromuscular control of posterior shoulder muscles to endure repetitively eccentric loading, which may improve posterior shoulder tightness and decrease the risk of subacromial pain. Nevertheless, no previous study investigated the influence of eccentric exercise on posterior shoulder tightness in overhead athletes. The aim of this study is to investigate the effects of shoulder eccentric exercise training on shoulder mobility, rotator cuff strength, pain and dysfunction, scapular kinematics and muscle activation in symptomatic overhead athletes with posterior shoulder tightness.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
40

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Taiwan
    • Beitou
      • Taipei, Beitou, Taiwan, 112304
        • Recruiting
        • National Yang Ming Chiao Tung University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participate in overhead sports over 4 hours per week
  • Age between 20 to 50 years old
  • Glenohumeral joint range of motion deficit: Shoulder internal rotation loss more than 15 degrees compared to the non-dominant side and total arc of motion loss more than 5 degrees or/and horizontal adduction range of motion lo more than 15 degrees compared to the non-dominant side
  • Shoulder impingement syndrome criteria

Exclusion Criteria:

  • History of shoulder dislocation, fracture and operation
  • History of direct contact in upper extremities or cervical region in the past one month
  • Shoulder pain or neurological symptom caused by cervical problem
  • VAS more than 5 during shoulder elevation
  • Receive treatment for posterior shoulder tightness in the past 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Eccentric-focused exercise group
Three eccentric-focused exercises addition to the general treatment group
Other: Eccentric-focused exercises

Three eccentric-focused exercises:

  1. Shoulder external rotator eccentric contraction in shoulder abduction 90 degree
  2. Shoulder external rotator eccentric contraction in shoulder abduction 0 degree
  3. Shoulder abductor eccentric contraction in shoulder abduction 90 degree
Other: Stretching exercises
  1. Modified sleeper stretch
  2. Modified cross-body stretch
Other: Hot pack
Hot pack application on shoulder region
Other: Massage
Massage for upper trapezius
Active Comparator: General treatment group
hot pack application on shoulder region upper trapezius massage two stretching exercises (modified sleeper stretch and modified cross-body stretch)
Other: Stretching exercises
  1. Modified sleeper stretch
  2. Modified cross-body stretch
Other: Hot pack
Hot pack application on shoulder region
Other: Massage
Massage for upper trapezius

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Shoulder range of motion (measured with goniometer)
Time Frame: 4 weeks
Shoulder external rotation, internal rotation, horizontal adduction range of motion in shoulder flexion 90 degrees
4 weeks
Rotator cuff functional strength ratio (Pro 4, Biodex Medical Systems, Inc., Shirley, NY, USA)
Time Frame: 4 weeks
Eccentric strength of shoulder external rotator and concentric strength of shoulder internal rotator are measured with isokinetic
4 weeks
Shoulder pain
Time Frame: 4 weeks
Pain is measured with Visual Analogue scale (VAS) Score range from 0 to 10. Scoring of 0 represents no pain and scoring of 10 represents pain as bad as it could possibly be.
4 weeks
Shoulder function
Time Frame: 4 weeks
Shoulder function is measured with Disability of the Arm, Shoulder and Hand questionnaire (DASH) Score range from 0 to 100. The higher of the score, the more disability.
4 weeks
Shoulder endurance test
Time Frame: 4 weeks
Participants will be instructed to execute a shoulder endurance test with the theraband®. Participants are asked to place their tested arm in a shoulder forward flexion 90-degree position, holding a 1-m long theraband® fixed at shoulder height on a graduated stick. Then, they are asked to pull the theraband® from the starting position to a 90-90 ending position at an alternated cadence given by a metronome. Males were asked to pull a green theraband® (2.1 kg) and females a red theraband ® (1.7 kg).
4 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Electromagnetic tracking system (Liberty electromagnetic tracking system, Polhemus , Colchester, VT,)
Time Frame: 4 weeks
Scapular kinematics during shoulder elevation task in scapular plane
4 weeks
Surface electromyography (TeleMyo 2400T G2, Noraxon USA Inc., Scottsdale, AZ, USA)
Time Frame: 4 weeks
Muscle activation of infraspinatus, upper trapezius, lower trapezius and serratus anterior during shoulder elevation task in scapular plane
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
National Yang Ming University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 9, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 22, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 31, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 17, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 22, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 31, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 23, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 22, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • YM110191F

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings